Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 12, 2019

Novartis’ Sandoz to buy Aspen’s Japanese business in $441m deal

Novartis division Sandoz has signed a binding agreement to acquire Aspen Global’s Japanese business in a deal valued at around €400m ($441m).

Image: Novartis’Sandoz has agreed to buy Aspen’s Japanese business. Photo: courtesy of Novartis.